| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Earth Science Tech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.21 |
| 52 Week High | US$0.33 |
| 52 Week Low | US$0.0002 |
| Beta | 1.82 |
| 11 Month Change | 0% |
| 3 Month Change | 236.00% |
| 1 Year Change | 483.33% |
| 33 Year Change | 1,066.67% |
| 5 Year Change | -72.00% |
| Change since IPO | -88.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ETST | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.004% | -2.4% |
| 1Y | 483.3% | 18.8% | 17.5% |
Return vs Industry: ETST exceeded the US Pharmaceuticals industry which returned 19% over the past year.
Return vs Market: ETST exceeded the US Market which returned 17.2% over the past year.
Price Volatility
| ETST volatility | |
|---|---|
| ETST Average Weekly Movement | 32.7% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ETST's share price has been volatile over the past 3 months.
Volatility Over Time: ETST's weekly volatility (33%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 32 | Giorgio Saumat | www.earthsciencetech.com |
Earth Science Tech, Inc. focuses on health and wellness industry. It operates Peaks, a telemedicine referral site focused on health and wellness for men and women; and operates pharmacy under the RxCompound name. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014.
Earth Science Tech, Inc. Fundamentals Summary
| ETST fundamental statistics | |
|---|---|
| Market cap | US$66.45m |
| Earnings (TTM) | US$812.14k |
| Revenue (TTM) | US$11.95m |
79.9x
P/E Ratio5.4x
P/S RatioIs ETST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ETST income statement (TTM) | |
|---|---|
| Revenue | US$11.95m |
| Cost of Revenue | US$4.13m |
| Gross Profit | US$7.83m |
| Other Expenses | US$7.02m |
| Earnings | US$812.14k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0026 |
| Gross Margin | 65.49% |
| Net Profit Margin | 6.79% |
| Debt/Equity Ratio | 4.1% |
How did ETST perform over the long term?
See historical performance and comparison